| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2a9ca0ae896d094873614f07e0a4901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bb46283f8c0b112b87b6210d9b7a6a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17352489f62bdc0f0b12c5c153ab5810 |
| publicationDate |
2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120029367-A |
| titleOfInvention |
Use of compounds for inducing differentiation of mesenchymal stem cells into chondrocytes |
| abstract |
The present invention provides a pharmaceutical composition for treating cartilage disease comprising the use of a compound of formula 1 for inducing differentiation of mesenchymal stem cells into chondrocytes and chondrocytes differentiated from mesenchymal stem cells by a compound of formula 1 do. Since the mesenchymal stem cells treated with the compound of Formula 1 are specifically induced to differentiate into cartilage cells, the mesenchymal stem cells can effectively treat cartilage diseases such as arthritis, cartilage damage and cartilage defects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101653197-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007229-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017131353-A1 |
| priorityDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |